Recommendations
• A reasonable A1C goal for many nonpregnant adults is <7% (53 mmol/mol). A
• Providers might reasonably suggest more stringent A1C goals (such as <6.5% [48 mmol/mol]) for selected individual patients if this can be achieved without significant hypoglycemia or other adverse effects of treatment (i.e., polypharmacy). Appropriate patients might include those with short duration of diabetes, type 2 diabetes treated with lifestyle or metformin only, long life expectancy, or no significant CVD. C
• Less stringent A1C goals (such as <8% [64 mmol/mol]) may be appropriate for patients with a history of severe hypoglycemia, limited life expectancy, advanced microvascular or macrovascular complications, extensive comorbid conditions, or long-standing diabetes in whom the goal is difficult to achieve despite diabetes self-management education, appropriate glucose monitoring, and effective doses of multiple glucose-lowering agents including insulin. B
REF.
'내분비내과 > 당뇨병' 카테고리의 다른 글
당뇨병 환자에서 고혈압 치료 권고 사항, 2018 ADA (0) | 2018.05.31 |
---|---|
Antihyperglycemic therapy, type 2 DM, 2018 ADA (0) | 2018.05.31 |
인크레틴 치료의 역사와 개발, History and development of incretin therapy (0) | 2018.05.17 |
DPP4 억제제 기전, DPP4 inhibitors, mechanism of action (0) | 2018.05.17 |
DPP4 억제제와 염증성 장 질환 위험 가능성, DPP4 inhibitors and possible risk of inflammatory bowel disease. (0) | 2018.05.17 |